|
Questionnaire Planned for DMFs to Boost ANDA Quality, Speed Reviews
To promote more thorough ANDA filings and faster reviews, the FDA’s Office of Generic Drugs (OGD) plans to extend its quality-based review (QbR) process to Type II drug master file (DMF) submissions, FDA officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives